261 related articles for article (PubMed ID: 29449105)
1. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
Tzanetakis M
Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
[TBL] [Abstract][Full Text] [Related]
2. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
Aldridge J; Décary-Hétu D
Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
[TBL] [Abstract][Full Text] [Related]
3. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
Aldridge J; Askew R
Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
[TBL] [Abstract][Full Text] [Related]
4. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
Van Hout MC; Hearne E
Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
[TBL] [Abstract][Full Text] [Related]
5. Safer scoring? Cryptomarkets, social supply and drug market violence.
Barratt MJ; Ferris JA; Winstock AR
Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
[TBL] [Abstract][Full Text] [Related]
6. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
[TBL] [Abstract][Full Text] [Related]
7. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
[TBL] [Abstract][Full Text] [Related]
8. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
[TBL] [Abstract][Full Text] [Related]
9. Assessing market competition and vendors' size and scope on AlphaBay.
Paquet-Clouston M; Décary-Hétu D; Morselli C
Int J Drug Policy; 2018 Apr; 54():87-98. PubMed ID: 29414490
[TBL] [Abstract][Full Text] [Related]
10. Who sells what? Country specific differences in substance availability on the Agora cryptomarket.
Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L
Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115
[TBL] [Abstract][Full Text] [Related]
11. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis.
Cunliffe J; Décary-Hêtu D; Pollak TA
Int J Drug Policy; 2019 Nov; 73():263-272. PubMed ID: 30772109
[TBL] [Abstract][Full Text] [Related]
12. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets.
Norbutas L; Ruiter S; Corten R
Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474
[TBL] [Abstract][Full Text] [Related]
13. An island apart? Risks and prices in the Australian cryptomarket drug trade.
Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
[TBL] [Abstract][Full Text] [Related]
14. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
Broséus J; Morelato M; Tahtouh M; Roux C
Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
[TBL] [Abstract][Full Text] [Related]
15. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network.
Norbutas L
Int J Drug Policy; 2018 Jun; 56():92-100. PubMed ID: 29621742
[TBL] [Abstract][Full Text] [Related]
16. Going international? Risk taking by cryptomarket drug vendors.
Décary-Hétu D; Paquet-Clouston M; Aldridge J
Int J Drug Policy; 2016 Sep; 35():69-76. PubMed ID: 27453145
[TBL] [Abstract][Full Text] [Related]
17. The recovery of online drug markets following law enforcement and other disruptions.
Van Buskirk J; Bruno R; Dobbins T; Breen C; Burns L; Naicker S; Roxburgh A
Drug Alcohol Depend; 2017 Apr; 173():159-162. PubMed ID: 28259089
[TBL] [Abstract][Full Text] [Related]
18. Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data.
Rhumorbarbe D; Staehli L; Broséus J; Rossy Q; Esseiva P
Forensic Sci Int; 2016 Oct; 267():173-182. PubMed ID: 27611957
[TBL] [Abstract][Full Text] [Related]
19. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
Barratt MJ; Lenton S; Maddox A; Allen M
Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539
[TBL] [Abstract][Full Text] [Related]
20. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
Moeller K; Munksgaard R; Demant J
Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
